SELLAS Life Sciences Group (SLS) Cash & Current Investments: 2011-2024
Historic Cash & Current Investments for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $21.0 million.
- SELLAS Life Sciences Group's Cash & Current Investments rose 425.77% to $21.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.1 million, marking a year-over-year decrease of 13.11%. This contributed to the annual value of $2.5 million for FY2023, which is 85.23% down from last year.
- As of Q3 2024, SELLAS Life Sciences Group's Cash & Current Investments stood at $21.0 million, which was up 129.92% from $9.1 million recorded in Q2 2024.
- SELLAS Life Sciences Group's Cash & Current Investments' 5-year high stood at $35.3 million during Q4 2020, with a 5-year trough of $2.5 million in Q4 2023.
- Over the past 3 years, SELLAS Life Sciences Group's median Cash & Current Investments value was $17.1 million (recorded in 2022), while the average stood at $15.7 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Cash & Current Investments soared by 795.72% in 2021 and then slumped by 85.23% in 2023.
- SELLAS Life Sciences Group's Cash & Current Investments (Quarterly) stood at $35.3 million in 2020, then slumped by 39.51% to $21.4 million in 2021, then declined by 19.81% to $17.1 million in 2022, then slumped by 85.23% to $2.5 million in 2023, then skyrocketed by 425.77% to $21.0 million in 2024.
- Its Cash & Current Investments stands at $21.0 million for Q3 2024, versus $9.1 million for Q2 2024 and $18.4 million for Q1 2024.